EPI-001, bicalutamide and enzalutamide inhibit homotypic (N/C-terminal) as well as heterotypic (coactivator) protein interactions by AR (39–41) that may be required for foci formation, respectively, phase separation in PCa cells. The gene discussed is AR; the disease is posterior cortical atrophy.